Skip to main content
Top
Published in: Inflammation 6/2022

02-07-2022 | Mood Disorders | Original Article

Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice

Authors: Ya-Jing Zhu, Jun-Juan Fan, Fang-Yi Wu, Ming Zhang, Ao-Qi Song, Yong Li, Yan-Kun Li, Wen-Ning Wu

Published in: Inflammation | Issue 6/2022

Login to get access

Abstract

NLRP1 inflammasome has been reported to participate in many neurological disorders. Our previous study has demonstrated that NLRP1 inflammasome is implicated in chronic stress-induced depressive-like behaviors in mice. Age has been reported to be related to depression. Here we examine whether NLRP1 inflammasome is involved in the effect of age on depressive disorder. Two chronic stress stimuli, chronic social defeat stress (CSDS) and repeat social defeat stress (RSDS), were used to establish a depression model in mice of different ages. We found that aged mice exhibited worse depressive-like behaviors and locomotor activity compared to young mice. Interestingly, the expression of hippocampal NLRP1 inflammasome complexes and the levels of the inflammatory cytokines were increased in an age-dependent manner. Also, chronic stress-induced increase in the expression of the hippocampal chemokine C-X-C motif ligand 1 (CXCL1), and its cognate receptor, CXC-motif receptor 2 (CXCR2), was more remarkable in aged mice than that in young mice. Moreover, aged mice exhibited lower hippocampal BDNF levels compared to young mice. Hippocampal Nlrp1a knockdown reduced the levels of pro-inflammatory cytokines and the expression of CXCL1/CXCR2, restored BDNF levels, and alleviated chronic stress-induced depressive-like behaviors in aged mice. Our results suggest that NLRP1 inflammasome-CXCL1/CXCR2-BDNF signaling contributes to the effect of age on chronic stress-induced depressive-like behavior in mice.
Literature
1.
go back to reference Ferrari, A.J., F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J. Murray, et al. 2013. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Medicine 10: e1001547.PubMedPubMedCentralCrossRef Ferrari, A.J., F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J. Murray, et al. 2013. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Medicine 10: e1001547.PubMedPubMedCentralCrossRef
2.
go back to reference Consortium. C. 2015. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523:588–91. Consortium. C. 2015. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523:588–91.
3.
go back to reference Zhang, J.C., W. Yao, and K. Hashimoto. 2016. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Current Neuropharmacology 14: 721–731.PubMedPubMedCentralCrossRef Zhang, J.C., W. Yao, and K. Hashimoto. 2016. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Current Neuropharmacology 14: 721–731.PubMedPubMedCentralCrossRef
4.
5.
go back to reference Duman, R.S., N. Li, R.J. Liu, V. Duric, and G. Aghajanian. 2012. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35–41.PubMedCrossRef Duman, R.S., N. Li, R.J. Liu, V. Duric, and G. Aghajanian. 2012. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35–41.PubMedCrossRef
6.
go back to reference Kohler, O., J. Krogh, O. Mors, and M.E. Benros. 2016. Inflammation in depression and the potential for anti-inflammatory treatment. Current Neuropharmacology 14: 732–742.PubMedPubMedCentralCrossRef Kohler, O., J. Krogh, O. Mors, and M.E. Benros. 2016. Inflammation in depression and the potential for anti-inflammatory treatment. Current Neuropharmacology 14: 732–742.PubMedPubMedCentralCrossRef
7.
go back to reference Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef
8.
go back to reference Haroon, E., C.L. Raison, and A.H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 37: 137–162.CrossRef Haroon, E., C.L. Raison, and A.H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 37: 137–162.CrossRef
9.
go back to reference Miller, A.H., and C.L. Raison. 2016. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology 16: 22–34.PubMedPubMedCentralCrossRef Miller, A.H., and C.L. Raison. 2016. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology 16: 22–34.PubMedPubMedCentralCrossRef
10.
go back to reference Mechawar, N., and J. Savitz. 2016. Neuropathology of mood disorders: do we see the stigmata of inflammation? Translational Psychiatry 6. Mechawar, N., and J. Savitz. 2016. Neuropathology of mood disorders: do we see the stigmata of inflammation? Translational Psychiatry 6.
11.
go back to reference Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, et al. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, et al. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef
12.
go back to reference Hiles, S.A., A.L. Baker, T. de Malmanche, and J. Attia. 2012. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity. Brain Behavior and Immunity 26: 1180–1188.PubMedCrossRef Hiles, S.A., A.L. Baker, T. de Malmanche, and J. Attia. 2012. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity. Brain Behavior and Immunity 26: 1180–1188.PubMedCrossRef
13.
go back to reference Yang, C.H., F.J. Bosker, J. Li, and R.A. Schoevers. 2018. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Bmc Psychiatry 18. Yang, C.H., F.J. Bosker, J. Li, and R.A. Schoevers. 2018. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Bmc Psychiatry 18.
14.
go back to reference Rethorst, C.D., M.S. Toups, T.L. Greer, P.A. Nakonezny, T.J. Carmody, B.D. Grannemann, et al. 2013. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry 18: 1119–1124.PubMedCrossRef Rethorst, C.D., M.S. Toups, T.L. Greer, P.A. Nakonezny, T.J. Carmody, B.D. Grannemann, et al. 2013. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry 18: 1119–1124.PubMedCrossRef
15.
go back to reference Tyring, S., A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, A. Wang, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 367: 29–35.PubMedCrossRef Tyring, S., A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, A. Wang, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 367: 29–35.PubMedCrossRef
17.
go back to reference Brahadeeswaran, S., N. Sivagurunathan, and L. Calivarathan. 2022. Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Molecular Neurobiology 2022. Brahadeeswaran, S., N. Sivagurunathan, and L. Calivarathan. 2022. Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Molecular Neurobiology 2022.
18.
go back to reference Calabrese, V., A. Santoro, D. Monti, R. Crupi, R. Di Paola, S. Latteri, et al. 2018. Aging and Parkinson’s disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology & Medicine 115: 80–91.CrossRef Calabrese, V., A. Santoro, D. Monti, R. Crupi, R. Di Paola, S. Latteri, et al. 2018. Aging and Parkinson’s disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology & Medicine 115: 80–91.CrossRef
19.
go back to reference Cicolari, S., A.L. Catapano, and P. Magni. 2021. Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mechanisms of Ageing and Development 195: 111467.PubMedCrossRef Cicolari, S., A.L. Catapano, and P. Magni. 2021. Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mechanisms of Ageing and Development 195: 111467.PubMedCrossRef
20.
go back to reference Franceschi, C., P. Garagnani, P. Parini, C. Giuliani, and A. Santoro. 2018. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology 14: 576–590.PubMedCrossRef Franceschi, C., P. Garagnani, P. Parini, C. Giuliani, and A. Santoro. 2018. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology 14: 576–590.PubMedCrossRef
21.
go back to reference Guan, S., X. Fang, and X. Hu. 2014. Factors influencing the anxiety and depression of patients with dilated cardiomyopathy. International Journal of Clinical and Experimental Medicine 7: 5691–5695.PubMedPubMedCentral Guan, S., X. Fang, and X. Hu. 2014. Factors influencing the anxiety and depression of patients with dilated cardiomyopathy. International Journal of Clinical and Experimental Medicine 7: 5691–5695.PubMedPubMedCentral
22.
go back to reference Latz, E., T.S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews Immunology 13: 397–411.PubMedCrossRef Latz, E., T.S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews Immunology 13: 397–411.PubMedCrossRef
23.
go back to reference Chavarria-Smith, J., and R.E. Vance. 2015. The NLRP1 inflammasomes. Immunological Reviews 265: 22–34.PubMedCrossRef Chavarria-Smith, J., and R.E. Vance. 2015. The NLRP1 inflammasomes. Immunological Reviews 265: 22–34.PubMedCrossRef
24.
go back to reference Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2011. A standardized protocol for repeated social defeat stress in mice. Nature Protocols 6: 1183–1191.PubMedPubMedCentralCrossRef Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2011. A standardized protocol for repeated social defeat stress in mice. Nature Protocols 6: 1183–1191.PubMedPubMedCentralCrossRef
25.
go back to reference Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2015. Corrigendum: A standardized protocol for repeated social defeat stress in mice. Nature Protocols 10: 643.PubMedCrossRef Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2015. Corrigendum: A standardized protocol for repeated social defeat stress in mice. Nature Protocols 10: 643.PubMedCrossRef
26.
go back to reference Eagle, A.L., C.E. Manning, E.S. Williams, R.M. Bastle, P.A. Gajewski, A. Garrison, et al. 2020. Circuit-specific hippocampal DeltaFosB underlies resilience to stress-induced social avoidance. Nature communications 11: 4484–4484.PubMedPubMedCentralCrossRef Eagle, A.L., C.E. Manning, E.S. Williams, R.M. Bastle, P.A. Gajewski, A. Garrison, et al. 2020. Circuit-specific hippocampal DeltaFosB underlies resilience to stress-induced social avoidance. Nature communications 11: 4484–4484.PubMedPubMedCentralCrossRef
27.
go back to reference McKim, D.B., M.D. Weber, A. Niraula, C.M. Sawicki, X. Liu, B.L. Jarrett, et al. 2018. Microglial recruitment of IL-1beta-producing monocytes to brain endothelium causes stress-induced anxiety. Molecular Psychiatry 23: 1421–1431.PubMedCrossRef McKim, D.B., M.D. Weber, A. Niraula, C.M. Sawicki, X. Liu, B.L. Jarrett, et al. 2018. Microglial recruitment of IL-1beta-producing monocytes to brain endothelium causes stress-induced anxiety. Molecular Psychiatry 23: 1421–1431.PubMedCrossRef
28.
go back to reference Song, A.Q., B. Gao, J.J. Fan, Y.J. Zhu, J. Zhou, Y.L. Wang, et al. 2020. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. Journal of Neuroinflammation 17: 178.PubMedPubMedCentralCrossRef Song, A.Q., B. Gao, J.J. Fan, Y.J. Zhu, J. Zhou, Y.L. Wang, et al. 2020. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. Journal of Neuroinflammation 17: 178.PubMedPubMedCentralCrossRef
30.
go back to reference Walsh, C.M., R.Z. Hill, J. Schwendinger-Schreck, J. Deguine, E.C. Brock, N. Kucirek, et al. 2019. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife 8. Walsh, C.M., R.Z. Hill, J. Schwendinger-Schreck, J. Deguine, E.C. Brock, N. Kucirek, et al. 2019. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife 8.
31.
go back to reference Seifert, B., R. Eckenstaler, R. Ronicke, J. Leschik, B. Lutz, K. Reymann, et al. 2016. Amyloid-beta induced changes in vesicular transport of BDNF in hippocampal neurons. Neural Plasticity 2016: 4145708.PubMedPubMedCentralCrossRef Seifert, B., R. Eckenstaler, R. Ronicke, J. Leschik, B. Lutz, K. Reymann, et al. 2016. Amyloid-beta induced changes in vesicular transport of BDNF in hippocampal neurons. Neural Plasticity 2016: 4145708.PubMedPubMedCentralCrossRef
32.
go back to reference Chai, H.H., X.C. Fu, L. Ma, H.T. Sun, G.Z. Chen, M.Y. Song, et al. 2019. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice. The FASEB Journal 33: 8853–8864.PubMedCrossRef Chai, H.H., X.C. Fu, L. Ma, H.T. Sun, G.Z. Chen, M.Y. Song, et al. 2019. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice. The FASEB Journal 33: 8853–8864.PubMedCrossRef
34.
go back to reference Kritsilis, M., S.V. Rizou, P.N. Koutsoudaki, K. Evangelou, V.G. Gorgoulis, and D. Papadopoulos. 2018. Ageing, cellular senescence and neurodegenerative disease. International Journal of Molecular Sciences 19. Kritsilis, M., S.V. Rizou, P.N. Koutsoudaki, K. Evangelou, V.G. Gorgoulis, and D. Papadopoulos. 2018. Ageing, cellular senescence and neurodegenerative disease. International Journal of Molecular Sciences 19.
35.
go back to reference Alzheimer’s A. 2016. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 2016 (12): 459–509. Alzheimer’s A. 2016. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 2016 (12): 459–509.
36.
go back to reference Floyd, R.A., and K. Hensley. 2002. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795–807. Floyd, R.A., and K. Hensley. 2002. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795–807.
37.
go back to reference Navarro, A., and A. Boveris. 2008. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Advanced Drug Delivery Reviews 60: 1534–1544.PubMedCrossRef Navarro, A., and A. Boveris. 2008. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Advanced Drug Delivery Reviews 60: 1534–1544.PubMedCrossRef
38.
go back to reference Maes, M., M. Berk, L. Goehler, C. Song, G. Anderson, P. Galecki, et al. 2012. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 10: 66.PubMedPubMedCentralCrossRef Maes, M., M. Berk, L. Goehler, C. Song, G. Anderson, P. Galecki, et al. 2012. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 10: 66.PubMedPubMedCentralCrossRef
39.
40.
go back to reference Yu, C.H., J. Moecking, M. Geyer, and S.L. Masters. 2018. Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice. Journal of Molecular Biology 430: 142–152.PubMedCrossRef Yu, C.H., J. Moecking, M. Geyer, and S.L. Masters. 2018. Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice. Journal of Molecular Biology 430: 142–152.PubMedCrossRef
41.
go back to reference Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends in Immunology 26: 447–454.PubMedCrossRef Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends in Immunology 26: 447–454.PubMedCrossRef
42.
go back to reference Yap, J.K.Y., B.S. Pickard, E.W.L. Chan, and S.Y. Gan. 2019. The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: Bringing neurons into the neuroinflammation game. Molecular Neurobiology 56: 7741–7753.PubMedCrossRef Yap, J.K.Y., B.S. Pickard, E.W.L. Chan, and S.Y. Gan. 2019. The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: Bringing neurons into the neuroinflammation game. Molecular Neurobiology 56: 7741–7753.PubMedCrossRef
43.
go back to reference Mawhinney, L.J., J.P.d.V. Rivero, G.A. Dale, R.W. Keane, and H.M. Bramlett. 2011. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neuroscience 12. Mawhinney, L.J., J.P.d.V. Rivero, G.A. Dale, R.W. Keane, and H.M. Bramlett. 2011. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neuroscience 12.
44.
go back to reference de Rivero Vaccari, J.P., F. Brand 3rd., S. Adamczak, S.W. Lee, J. Perez-Barcena, M.Y. Wang, et al. 2016. Exosome-mediated inflammasome signaling after central nervous system injury. Journal of Neurochemistry 136 (Suppl 1): 39–48.PubMedCrossRef de Rivero Vaccari, J.P., F. Brand 3rd., S. Adamczak, S.W. Lee, J. Perez-Barcena, M.Y. Wang, et al. 2016. Exosome-mediated inflammasome signaling after central nervous system injury. Journal of Neurochemistry 136 (Suppl 1): 39–48.PubMedCrossRef
45.
go back to reference Pontillo, A., E. Catamo, B. Arosio, D. Mari, and S. Crovella. 2012. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Disease and Associated Disorders 26: 277–281.PubMedCrossRef Pontillo, A., E. Catamo, B. Arosio, D. Mari, and S. Crovella. 2012. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Disease and Associated Disorders 26: 277–281.PubMedCrossRef
46.
go back to reference Fan, J.J., B. Gao, A.Q. Song, Y.J. Zhu, J. Zhou, W.Z. Li, et al. 2020. Spinal cord NLRP1 inflammasome contributes to dry skin induced chronic itch in mice. Journal of Neuroinflammation 17: 122.PubMedPubMedCentralCrossRef Fan, J.J., B. Gao, A.Q. Song, Y.J. Zhu, J. Zhou, W.Z. Li, et al. 2020. Spinal cord NLRP1 inflammasome contributes to dry skin induced chronic itch in mice. Journal of Neuroinflammation 17: 122.PubMedPubMedCentralCrossRef
47.
go back to reference Begni, V., M.A. Riva, and A. Cattaneo. 2017. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions. Clinical Science (London, England) 131: 123–138.CrossRef Begni, V., M.A. Riva, and A. Cattaneo. 2017. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions. Clinical Science (London, England) 131: 123–138.CrossRef
48.
go back to reference Jin. W. 2020. Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson’s disease. Journal of Clinical Medicine 9. Jin. W. 2020. Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson’s disease. Journal of Clinical Medicine 9.
49.
50.
go back to reference Chan, M.F., J. Li, A. Bertrand, A.J. Casbon, J.H. Lin, I. Maltseva, et al. 2013. Protective effects of matrix metalloproteinase-12 following corneal injury. Journal of Cell Science 126: 3948–3960.PubMedPubMedCentral Chan, M.F., J. Li, A. Bertrand, A.J. Casbon, J.H. Lin, I. Maltseva, et al. 2013. Protective effects of matrix metalloproteinase-12 following corneal injury. Journal of Cell Science 126: 3948–3960.PubMedPubMedCentral
51.
go back to reference Giacobbo, B.L., J. Doorduin, H.C. Klein, R. Dierckx, E. Bromberg, and E.F.J. de Vries. 2019. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Molecular Neurobiology 56: 3295–3312.CrossRef Giacobbo, B.L., J. Doorduin, H.C. Klein, R. Dierckx, E. Bromberg, and E.F.J. de Vries. 2019. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Molecular Neurobiology 56: 3295–3312.CrossRef
52.
go back to reference Komulainen, P., M. Pedersen, T. Haenninen, H. Bruunsgaard, T.A. Lakka, M. Kivipelto, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study. Neurobiology of Learning and Memory 90: 596–603.PubMedCrossRef Komulainen, P., M. Pedersen, T. Haenninen, H. Bruunsgaard, T.A. Lakka, M. Kivipelto, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study. Neurobiology of Learning and Memory 90: 596–603.PubMedCrossRef
Metadata
Title
Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice
Authors
Ya-Jing Zhu
Jun-Juan Fan
Fang-Yi Wu
Ming Zhang
Ao-Qi Song
Yong Li
Yan-Kun Li
Wen-Ning Wu
Publication date
02-07-2022
Publisher
Springer US
Published in
Inflammation / Issue 6/2022
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01683-4

Other articles of this Issue 6/2022

Inflammation 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine